Author: eMedNews
Pembrolizumab After RCC Surgery: Potential New Standard of Care
Pembrolizumab following surgery for clear cell renal cell carcinoma (RCC) may offer a potential new.
The Total Knockout: Towards Personalized Anesthesia
A team of researchers at the École Polytechnique fédérale de Lausanne (EPFL; Lausanne, Switzerland) have.
Surgical Data Support Nivolumab Plus Chemotherapy for Resectable NSCLC
Administration of neoadjuvant nivolumab plus chemotherapy did not affect the feasibility or timing of surgery.
Researchers Analyze Carbon Footprint of Planned Neutrino Experiment
The annual greenhouse gas emissions of a planned neutrino experiment could be on a par.
The Link Between Too Much Caffeine and Glaucoma
Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold.
Avellino Launches AvaGen as First Genetic Test
Avellino Launches AvaGen as First Genetic Test to Quantify Keratoconus Risk and Presence of Corneal.
Is Being ‘Hangry’ Really a Thing ― or Just an Excuse?
It’s one thing to crave a big meal or a bottomless bag of your favorite.
Localized Prostate Cancer Therapy: Interview with Shyam Natarajan, CEO of Avenda Health
Avenda Health, a medtech company based in Santa Monica, California has developed the Focal Therapy.
Cedars-Sinai, Rubedo Partner to Develop Targeted IPF Treatments
Rubedo Life Sciences announced that it has partnered with Cedars-Sinai Medical Center, also in California, to.
Rare 2030 Action Campaign Pushing for European Plan for Rare Diseases
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European.